nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000457	0.000457	CcSEcCtD
Entacapone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000455	CcSEcCtD
Entacapone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Entacapone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00045	0.00045	CcSEcCtD
Entacapone—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Entacapone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Entacapone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000446	0.000446	CcSEcCtD
Entacapone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.000446	CcSEcCtD
Entacapone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Entacapone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Entacapone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Entacapone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Entacapone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Entacapone—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Entacapone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Entacapone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Entacapone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Entacapone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Entacapone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Entacapone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Entacapone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Entacapone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Entacapone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Entacapone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Entacapone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Entacapone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Entacapone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Entacapone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Entacapone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Entacapone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Entacapone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Entacapone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Entacapone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Entacapone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Entacapone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Entacapone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Entacapone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Entacapone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Entacapone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Entacapone—Pain—Etoposide—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Entacapone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Entacapone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Entacapone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Entacapone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Entacapone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Entacapone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Entacapone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000398	CcSEcCtD
Entacapone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000398	CcSEcCtD
Entacapone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Entacapone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Entacapone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Entacapone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Entacapone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Entacapone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Entacapone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Entacapone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Entacapone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Entacapone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000387	CcSEcCtD
Entacapone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Entacapone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Entacapone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Entacapone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000385	0.000385	CcSEcCtD
Entacapone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Entacapone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Entacapone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Entacapone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Entacapone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Entacapone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Entacapone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Entacapone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000374	CcSEcCtD
Entacapone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Entacapone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Entacapone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Entacapone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Entacapone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Entacapone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Entacapone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Entacapone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Entacapone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00037	0.00037	CcSEcCtD
Entacapone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00037	CcSEcCtD
Entacapone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Entacapone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Entacapone—Rash—Vincristine—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Entacapone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Entacapone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Entacapone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Entacapone—Headache—Vincristine—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Entacapone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Entacapone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000362	CcSEcCtD
Entacapone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Entacapone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Entacapone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Entacapone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Entacapone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Entacapone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000351	CcSEcCtD
Entacapone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Entacapone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Entacapone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Entacapone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Entacapone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Entacapone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Entacapone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Entacapone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Entacapone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Entacapone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000329	CcSEcCtD
Entacapone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Entacapone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Entacapone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Entacapone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000322	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Entacapone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Entacapone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Entacapone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Entacapone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Entacapone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Entacapone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000314	CcSEcCtD
Entacapone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000312	0.000312	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000312	CcSEcCtD
Entacapone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Entacapone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Entacapone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Entacapone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Entacapone—Rash—Etoposide—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Entacapone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Entacapone—Headache—Etoposide—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Entacapone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Entacapone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000295	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Entacapone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000293	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Entacapone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Entacapone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Entacapone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Entacapone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000289	CcSEcCtD
Entacapone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Entacapone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Entacapone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Entacapone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Entacapone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Entacapone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Entacapone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Entacapone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Entacapone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Entacapone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Entacapone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Entacapone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Entacapone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Entacapone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000269	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000269	CcSEcCtD
Entacapone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Entacapone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Entacapone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Entacapone—Shock—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Entacapone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Entacapone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Entacapone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000256	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000256	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000256	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000254	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Entacapone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00025	CcSEcCtD
Entacapone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Entacapone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Entacapone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Entacapone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00024	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00024	CcSEcCtD
Entacapone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000237	CcSEcCtD
Entacapone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000236	CcSEcCtD
Entacapone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Entacapone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Entacapone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00023	0.00023	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Entacapone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000228	CcSEcCtD
Entacapone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Entacapone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000223	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000222	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Entacapone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Entacapone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000216	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000216	CcSEcCtD
Entacapone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000213	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Entacapone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00021	CcSEcCtD
Entacapone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Entacapone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Entacapone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.0002	CcSEcCtD
Entacapone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000194	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000194	CcSEcCtD
Entacapone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00019	CcSEcCtD
Entacapone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Entacapone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000181	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00018	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000176	CcSEcCtD
Entacapone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Entacapone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000173	CcSEcCtD
Entacapone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000168	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000168	CcSEcCtD
Entacapone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000167	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000167	CcSEcCtD
Entacapone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000166	CcSEcCtD
Entacapone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000162	CcSEcCtD
Entacapone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000157	CcSEcCtD
Entacapone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000156	CcSEcCtD
Entacapone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000154	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000154	CcSEcCtD
Entacapone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000153	CcSEcCtD
Entacapone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000145	CcSEcCtD
